Use of inhibitors of the activity or function of PI3K in the treatment of primarily Sjögren's syndrome

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

BIETH, Bruno,BURKHART, Christoph,CHRIST, Andreas,DE BUCK, Stefan,KALIS, Christoph,LINDGREN, Sam

申请号：

DK17704548

公开号：

DK3413894T3

申请日:

2017.02.10

申请国别(地区):

DK

年份:

2020

代理人:

摘要：

The invention relates to the use of 1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-ylamino]-pyrrolidin-1-yl}-propan-1-one or pharmaceutically acceptable salts thereof for the treatment of primary Sjögren's Syndrome.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/